Affiliation:
1. University of California, Davis School of Medicine Department of Neurology, University of California Davis; Davis California USA
Funder
Myasthenia Gravis Foundation of America, October 2015, Honolulu, Hawaii
Subject
Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology
Reference33 articles.
1. 3,4-Diaminopyridine;Rubin-Preminger;Acta Crystallogr E,2007
2. Current therapy for Lambert-Eaton myasthenic syndrome: development of 3,4-diaminopyridine phosphate salt as first-line symptomatic treatment;Quartel;Curr Med Res Opin,2010
3. 3,4-Diaminopyridine in childhood myasthenia: double-blind, placebo-controlled trial;Anlar;J Child Neurol,1996
4. Kv3 voltage-gated potassium channels regulate neurotransmitter release from mouse motor nerve terminals;Brooke;Eur J Neurosci,2004
5. Inotropic effects of the K + channel blocker 3,4-diaminopyridine on fatigued diaphragm muscle;Ionno;Respir Physiol Neurobiol,2008
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献